Ifeanyichukwu Ifechidere: The Cell-Based Model of Haemostasis
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:
“The Cell-Based Model of Haemostasis.
Why the waterfall cascade is a teaching fiction — and what actually happens on cell surfaces in vivo.
You learned the coagulation cascade in a diagram. Neat arrows.
Sequential activation. Intrinsic pathway meets extrinsic pathway at Factor X. Clean. Logical. Memorable.
The waterfall cascade was never designed to reflect physiology.
It was designed to explain test tube behaviour.
And we have been teaching it as biological truth ever since.
Let’s update the mental model.
What the cascade cannot explain:
- Why patients with severe Factor XII deficiency don’t bleed — despite APTT prolongation
- Why haemophilia A and B cause serious bleeding despite an intact extrinsic pathway
- Why Factor VIIa works therapeutically even in non-haemophiliac bleeding
- Why thrombin generation is far more nuanced than sequential factor activation suggests
The cascade model has no answers for these. The cell-based model does.
The Cell-Based Model — three overlapping phases, three distinct cell surfaces:
- Initiation — on Tissue Factor-bearing cells
Haemostasis begins when vascular injury exposes Tissue Factor.
TF binds circulating Factor VIIa to form the TF:VIIa complex — generating small, insufficient amounts of thrombin.
Not enough to form a clot. Just enough to prime what comes next.
- Amplification — on the platelet surface
That small thrombin burst activates platelets.
Activated platelets amplify the signal — activating Factor V, Factor VIII, and Factor XI on their phospholipid surface.
The coagulation machinery assembles. The stage is set.
- Propagation — on the activated platelet surface
Tenase and prothrombinase complexes assemble at scale.
Factor Xa and Factor Va drive explosive thrombin generation — converting fibrinogen to fibrin, activating FXIII for cross-linking, and producing a stable, robust clot.
Thrombin is the amplifier, the activator, and the architect of the entire system.
Understanding cell-based haemostasis reframes everything:
- Why global assays like TEG and ROTEM reflect physiology better than PT/APTT alone
- Why platelet-poor plasma tells an incomplete haemostatic story
- Why Tissue Factor is the true physiological trigger — not Factor XII contact activation
The cascade is not wrong to teach as an introduction.
But stopping there is a disservice to every scientist and clinician making decisions at the bedside.
Coagulation happens on surfaces. In phases. With cells at the centre of every step.
The test tube taught us the factors.
The cell-based model teaches us the biology.
Think in physiology.
That is what separates a scientist who reports results from one who truly interprets them.
Was the cell-based model taught in your training — or did you discover it later?
Repost to put real haemostasis physiology in front of every scientist and clinician who needs it.”
Find more posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.
-
Jun 9, 2026, 13:13James P. Crowley: How Collaboration and Long-Term Research Led to a Nobel Prize–Winning Discovery by Harvey Alter
-
Jun 9, 2026, 13:09Manjot Kaur: Deep Vein Thrombosis Prevention During Long Distance Travel
-
Jun 9, 2026, 11:36Chris Boshoff: FDA Approves Our Treatment for Hemophilia A and B for 2 New Patient Populations
-
Jun 9, 2026, 10:52Vaidehi Prasanth: The Role of Viscoelastic Testing in Low- and Middle-Income Countries
-
Jun 9, 2026, 10:37Maria Bruzelius: Hemophilia and Bleeding Disorder in Clinical Practice at NordCoag 2026
-
Jun 9, 2026, 10:02Understanding Factor X Deficiency – ICHCC
-
Jun 9, 2026, 09:49Lee Severin: Why Patients Love Platelet-Rich Plasma
-
Jun 9, 2026, 09:42Lorena Gerlach: Blood Transportation Duty on this Muggy Spring Day
-
Jun 9, 2026, 08:54Shujha Abbas: Understanding the Real Cost of Gene Therapie